4//SEC Filing
Hull Hans 4
Accession 0001746473-25-000015
CIK 0001746473other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 6:07 PM ET
Size
15.2 KB
Accession
0001746473-25-000015
Insider Transaction Report
Form 4
Hull Hans
Chief Business Officer
Transactions
- Award
Common Stock
2025-01-23+40,150→ 251,708 total - Award
Stock Option (Right to Buy)
2025-01-23+80,300→ 80,300 totalExercise: $11.14Exp: 2035-01-23→ Common Stock (80,300 underlying)
Holdings
- 3,821(indirect: See Footnote)
Common Stock
- 13,985(indirect: See footnote)
Common Stock
- 13,985(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.
- [F2]The shares are held by The Sloger Hull Family Trust. The Reporting Person and his spouse serve as trustees for the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F3]The shares are held by a trust for the Reporting Person's minor child ("Child A Trust"). The Reporting Person and his spouse serve as trustees for Child A Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]The shares are held by a trust for the Reporting Person's minor child ("Child B Trust"). The Reporting Person and his spouse serve as trustees for Child B Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F5]1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
PLIANT THERAPEUTICS, INC.
CIK 0001746473
Entity typeother
Related Parties
1- filerCIK 0001614876
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 6:07 PM ET
- Size
- 15.2 KB